Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00198120 · ClinicalTrials.gov registry record · Phase 3
Safety and Effectiveness of D-Cycloserine in Children With Autism
A Phase 3 study, sponsored by Indiana University.
- Completed
- Registry status
- Phase 3
- Development phase
- 80
- Enrollment target
NCT00198120: Completed Phase 3 study, sponsored by Indiana University.
NCT00198120 is a Phase 3 study that has completed, run by Indiana University. The registered enrollment target is 80 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00198120, a Phase 3 study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 80 participants
- Enrollment target
Study Summary
This study will determine the effectiveness of D-cycloserine in reducing symptoms of autism in autistic children.
Primary Outcome
All randomized subjects in the Double-Blind Phase will be assessed for change.
Interventions
- DRUG Placebo
- DRUG D-cycloserine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2004-02 |
| Est. Completion | 2010-08 |
| Phase | Phase 3 |
What the finished NCT00198120 record still lists
NCT00198120 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (90% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00198120 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00198120 about?
NCT00198120 is a clinical study titled "Safety and Effectiveness of D-Cycloserine in Children With Autism". This study will determine the effectiveness of D-cycloserine in reducing symptoms of autism in autistic children.
What is the current status of trial NCT00198120?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 80 participants. The study started on 2004-02. Estimated completion is 2010-08.
What interventions are being tested in trial NCT00198120?
The interventions under investigation include: Placebo (DRUG), D-cycloserine (DRUG).
Who is sponsoring clinical trial NCT00198120?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00198120's enrollment target sits among peer trials
80 1755th of 2000 higher than 233 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia